NEWS

New funding puts Viral Vector Manufacturing Facility in winning position

Children’s Medical Research Institute warmly welcomes the NSW Government’s announcement of its allocation in the 2022/23 Budget of $101.4m toward a commercial-scale Viral Vector Manufacturing Facility. This significant investment will greatly advance the ability to treat children with serious genetic diseases. In addition to funds to build the manufacturing facility, the $101.4 million commitment includesContinue reading “New funding puts Viral Vector Manufacturing Facility in winning position”

Partnership for RNA Project

Scientists from Children’s Medical Research Institute (CMRI) have partnered with RNA researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) to combine mRNA delivery with viral gene delivery to treat metabolic liver disease in infants and children. The partnership will be funded by a $99k grant from the mRNA Victoria Research Acceleration Fund along with grantsContinue reading “Partnership for RNA Project”

New research facility to deliver life-saving medical technology in Western Sydney

CMRI is delighted by the NSW Government’s announcement about the establishment of Australia’s ​first commercial-scale viral vector manufacturing facility in the Westmead Health and Innovation District. The ability to manufacture high-quality (clinical grade) viral vectors in Australia is critically important for our gene therapy programs. It will accelerate the delivery of, and access to, life-saving new gene therapies developed in the CMRI labsContinue reading “New research facility to deliver life-saving medical technology in Western Sydney”

Loading…

Something went wrong. Please refresh the page and/or try again.

Get new content delivered directly to your inbox.

%d bloggers like this: